Virocan is an R&D driven company actively engaged in developing and acquiring intellectual property. Virocan has been aggressive in creating and protecting its deep and diverse intellectual property portfolio. The company´s patents and patents-pending cover a wide variety of areas across multiple discovery programs. They include, but are not limited to, novel drug delivery of viral and protein-based theragnostic agents involving RNA interference.